The 12th meeting of the 11th board of directors and the 11th meeting of the 10th board of supervisors held to review and approve the annual work report and other relevant proposals
Release time:
2023-04-21
General Manager's report pointed out that in 2022, my country's macroeconomic policy will adhere to the general tone of seeking progress while maintaining stability. The annual GDP was 121.02 trillion billion yuan, an increase of 3.0 percent over last year (data source: National Bureau of Statistics). Centering on the general policy of "reform, breakthrough, innovation and development", the company strives to maintain the orderly development of various production and operation work, achieving operating income of 3.56 billion yuan for the whole year, a decrease of 6.43 percent over the same period last year, and net profit attributable to shareholders of 0.288 billion yuan, a decrease of 68.86 percent over the same period last year. By the end of 2022, the company's total assets were 7.321 billion billion yuan, up 4.22 percent year-on-year, and the net assets attributable to shareholders of listed companies were 5.186 billion billion yuan, down 0.41 percent year-on-year.
2022
, the company's industrial chain extension war made new progress. The company set up Yunnan Jianfeng New Building Materials Co., Ltd. to promote its aggregate, machine sand and other projects in an orderly manner, and Yunnan Jianfeng invested 0.133 billion yuan to increase the capital of its subsidiary Jianfeng Exhibition, making it a holding enterprise of the company, and the company's cement business sector has been further developed.
Facing the unfavorable external environment, the company's cement companies continue to implement benchmarking and refined management, steadily implement various technical reforms, strictly control production costs, strive to overcome the pressure of declining demand, and actively expand the sales market. Daye Peak has improved the overall production capacity of the kiln system through technical transformation and operation process optimization of grate cooler, packaging machine and kiln cylinder, combined with the use of MES system for optimal parameter traceability. Actively develop new agents, open up new markets, strengthen cooperation with large enterprises, undertake key projects, effectively cope with the overall weak cement market and maintain the balance of production and sales; vigorously promote the construction of green mines and green factories, and successfully entered the list of national green factories in 2022. Yunnan Jianfeng has strengthened the technological transformation of energy saving and consumption reduction, reformed the kiln head sealing device, grate cooler and other equipment, and improved the kiln output. The dust collector at the bottom of the cement blending warehouse has been added, and the feeding device of the roller press has been reformed, effectively improving the production site environment. Actively implement the brand strategy, adhere to the "direct sales + agent" dual-track sales model, while effectively reducing the sales cost while maintaining the advantages of multi-channel sales. Huang Ping Jianfeng actively studied, explored and applied advanced technology to tackle key problems. Through the transformation of the cone under the decomposition furnace to reduce negative pressure fluctuation, replace the high-temperature feed lock valve, and increase the snowman pushing device of the grate cooler, the stability of the equipment has been improved. Facing the unfavorable demand situation, it actively undertakes key projects externally and strengthens the business skills training of the marketing team internally, with Kaili and Huang Ping as the core markets, maintain the leading sales of the same type of kiln line in the region.2022
, the company's pharmaceutical sector technical reform and engineering construction continued to advance, innovation and research and development to make new progress. Jianfeng Pharmaceutical's annual production of 2 billion tablets of solid preparations (international project) has completed the completion acceptance of construction projects, equipment installation and debugging, certified product registration batch production, completed the human bioequivalence test, submitted registration materials, and entered the waiting stage of cGMP application for certification; jinxi Production Base has completed the completion and acceptance of the technical transformation project of bulk drugs, completed the installation and debugging of the newly added RTO incineration treatment facilities, completed the automatic transformation of the packaging equipment of freeze-dried powder injection and solid preparation production line, and completed the transformation of the refrigeration system of the raw material workshop and the comprehensive preparation building. The construction of the single-dose eye drop production line of Jianfeng Pharmaceutical has also been basically completed and has entered the stage of product stability inspection. The 205 and 206 workshops of Anhui Xinbeika Phase II Project have been completed and put into trial production. The chlorine dioxide workshop has completed the information control transformation and improved the safety guarantee level. The technical renovation project of Moxi Xiaohuan and pharmaceutical intermediates in Jianfeng Beika 102 Workshop has been completed and put into trial operation. The 203, 205 and 206 workshops have been completed and have entered the stage of production plan review. Jianfeng Pharmaceutical and its subsidiaries further increased investment in research and development, continued to promote the phase I clinical trials of the new anti-tumor drug DPT and JFAN-1001 project, and completed the application for production registration of several products such as fluprost eye drops, single-dose sodium hyaluronate eye drops, and mycophenolate mofetil capsules. At present, 11 drugs (including consistency evaluation) have been submitted to the State Drug Administration for production registration.
On the same day, the company also held the 11th meeting of the 10th Board of Supervisors, and reviewed and approved 5 related reports and proposals including the 2022 Board of Supervisors Report of the company. (residual fruit)
More information
In the eastern corner of the production area of Jianfeng Health Technology Company, there is a very inconspicuous building. From below, only a few pipes of uneven thickness can be seen on the top and the slogan "Focus on Environmental Protection and Promote Sustainable Development" with red letters on the yellow background on the stainless steel guardrail. Walking up, you can only see several closed pools and a small room with stacks of documents, test tubes, glass bottles and other testing tools on the table. This is the peak and healthy sewage treatment station. The production sewage of the whole factory area is concentrated here. After adjustment (PH adjustment), pre-acidification, anaerobic, anoxic, aerobic (aeration), precipitation and other links, it is discharged into the pipe network after reaching the special discharge standard. Yin Zhiwu, executive deputy general manager of Jianfeng Health, said that because the sewage treatment station in Wucheng District has not yet been built, Jianfeng Health has not yet been able to achieve pipe discharge, and the relevant national laws have strict requirements on the discharge of water pollutants from the extraction pharmaceutical industry. Sewage discharge must reach a special discharge limit, that is, chemical oxygen demand (COD) must be less than 50 mg/L. Enterprise development and environmental protection are both the concept of peak health since its establishment. In March this year, on the basis of the original environmental protection facilities, Jianfeng Health carried out technical renovation of waste gas collection and treatment facilities, and at the same time installed a sealing cover on the sewage treatment station to realize the closed collection of waste gas. Since the trial operation of this facility in mid-May, the overall effect has been obvious. The original treatment tank would emit an unpleasant smell during work, but now the smell has been significantly reduced. Compared with the young enterprise of peak health, the relatively "older" peak pharmaceutical has more experience in sewage treatment and environmental protection. Akihama
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-30
Jianfeng Pharmaceutical Won Advanced Collective of Municipal Red Cross Humanitarian Promotion Award
On April 24, the Red Cross Society of Jinhua issued a circular commending the advanced units and individuals of the 2016 Red Cross Humanitarian Promotion Award. Peak Pharmaceutical Company won the Red Cross Humanitarian Promotion Award for Advanced Collective. The Red Cross is a social relief organization engaged in humanitarian work, with the purpose of carrying forward the spirit of humanity, fraternity and dedication, protecting human life and health, and promoting the cause of peace and progress of mankind. As a socially responsible enterprise, Jianfeng Pharmaceutical has always attached importance to public welfare and charity work, vigorously promoted the spirit of the Red Cross, and vigorously supported the work of the Red Cross with practical actions. In September 2016, at the theme publicity activity of "World First Aid Day" and the opening ceremony of the municipal Red Cross emergency rescue station (point), Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, donated 6 AEDs known as "life-saving artifact" to the Red Cross on behalf of Jianfeng Pharmaceutical, it is equipped with six Red Cross emergency rescue service stations (points), namely, Jinhua high-speed railway station, sports center, cultural center, Shuanglong scenic spot, Siping village scenic spot and Suoyuan village scenic spot. The configuration of AED equipment has played a very good role in improving the emergency rescue capacity of Jinhua's key locations, and has been affirmed by the Red Cross and related units. (Spike Pharmaceuticals)
2020
07-31
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page